ARCHIVES

Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs

This article is from The Cancer Letter archive.

Vol. 16 No. 34 | September 7, 1990

Download PDF Visit The Full Archive

Related Articles

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

May 22, 1981

NIH Director Collins Publishes Third Book About Faith In God

March 5, 2010

NCAB Cancer Centers committee recommends Ratio Cap To Limit Growth of Largest Grants

February 14, 1992

NIH Slow To Implement Equality In Studies, GAO Says, But Waxman Assures Reauthorization

June 22, 1990

In Brief: Durant New President Of AACI, Ultmann Named President-Elect; Farber Center Gets New Name

February 4, 1983

Senate Raises Funding For Cervical, Ovarian, Prostate Cancer

September 18, 1992